Description

Clexane (enoxaparin) solution for injections syringe 40 mg. 0.4 ml. №10

Ingredients:

Each syringe contains 40 mg of enoxaparin sodium.

Dosage:

The usual dose is 1 mg per kilogram of body weight, injected subcutaneously once daily.

Indications:

Clexane is indicated for the prevention of blood clots in various conditions such as deep vein thrombosis and pulmonary embolism.

Contraindications:

Do not use Clexane if you have active major bleeding or a history of heparin-induced thrombocytopenia.

Directions:

Administer the injection exactly as directed by your healthcare provider. Do not self-inject unless instructed.

Scientific Evidence:

Enoxaparin, the active ingredient in Clexane, is a low molecular weight heparin that works by inhibiting the formation of blood clots. Studies have shown that enoxaparin is effective in preventing venous thromboembolism in various clinical settings, including orthopedic surgery and medical patients at risk of clot formation.

Additional Information:

Clexane is a widely used anticoagulant with a well-established safety and efficacy profile. It is preferred in many clinical scenarios due to its predictable anticoagulant effect and lower risk of side effects compared to unfractionated heparin. However, like all anticoagulants, it carries a risk of bleeding, and close monitoring is necessary during therapy.

Research has also indicated that enoxaparin may have additional benefits beyond its anticoagulant properties, such as anti-inflammatory effects and potential anti-cancer properties. Further studies are ongoing to explore these potential benefits and optimize the use of enoxaparin in various clinical conditions.